MX166995B - Purificacion del factor de necrosis tumoral mediane membranas de politetrafluroetileno microporosas - Google Patents

Purificacion del factor de necrosis tumoral mediane membranas de politetrafluroetileno microporosas

Info

Publication number
MX166995B
MX166995B MX026926A MX2692686A MX166995B MX 166995 B MX166995 B MX 166995B MX 026926 A MX026926 A MX 026926A MX 2692686 A MX2692686 A MX 2692686A MX 166995 B MX166995 B MX 166995B
Authority
MX
Mexico
Prior art keywords
tnf
necrosis factor
tumor necrosis
polyetetrafluroethylene
microporous
Prior art date
Application number
MX026926A
Other languages
English (en)
Inventor
James William Thomson
Sidney Norman Wolfe
Wolfgang Helmut Hanisch
Leo Shun-Lee Lin
Ralph Yamamoto
Glenn Dorin
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/792,815 external-priority patent/US4677197A/en
Priority claimed from US06/866,213 external-priority patent/US4894439A/en
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of MX166995B publication Critical patent/MX166995B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método para purificar un factor de necrosis tumoral (TNF) obtenido a partir de células huespedes recombinables conductoras de TNF, caracterizado porque comprende las siguientes etapas: a) obtener un fluido que contiene TNF a partir de células huespedes recombinables productores de TNG; b) hacer pasar el fluido que contiene TNF a través de una matriz porosa hidrofóbica continua para producir un TNF purificado parcialmente; c) purificar adicionalmente dicho TNF purificado parcialmente mediante por lo menos una etapa de cromatografía de matriz de interacción hidrofóbica y por lo menos una etapa de cromatografía de matriz de intercambio aniónica; d) recuperar el TNF purificado que tiene un contenido de TNF de por lo menos 95 por ciento, de acuerdo como se determina por medio del análisis SDS-PAGE y un contenido de endotoxina inferior a 0.1 ng/mg de THF
MX026926A 1985-10-30 1986-10-29 Purificacion del factor de necrosis tumoral mediane membranas de politetrafluroetileno microporosas MX166995B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/792,815 US4677197A (en) 1985-10-30 1985-10-30 Purification method for tumor necrosis factor
US06/866,213 US4894439A (en) 1986-05-22 1986-05-22 N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes

Publications (1)

Publication Number Publication Date
MX166995B true MX166995B (es) 1993-02-19

Family

ID=27121338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX026926A MX166995B (es) 1985-10-30 1986-10-29 Purificacion del factor de necrosis tumoral mediane membranas de politetrafluroetileno microporosas

Country Status (9)

Country Link
EP (1) EP0220966A3 (es)
AU (1) AU6449586A (es)
CA (1) CA1286843C (es)
DK (1) DK520086A (es)
FI (1) FI864412A (es)
IL (1) IL80448A (es)
MX (1) MX166995B (es)
NO (1) NO864321L (es)
NZ (1) NZ218103A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689401A (en) * 1986-03-06 1987-08-25 Cetus Corporation Method of recovering microbially produced recombinant ricin toxin a chain
JPS62298536A (ja) * 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US4808314A (en) * 1987-09-18 1989-02-28 Scripps Clinic And Research Foundation Method for reducing bacterial endotoxin contamination in solutions of macromolecules
PT88783B (pt) * 1987-10-23 1993-01-29 Smithkline Beckman Corp Processo de purificacao de proteina t4 soluvel e de producao da mesma
CA1341379C (en) * 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
LT3062B (en) 1992-09-03 1994-10-25 Fermentas Biotech Inst Method for preparing recombinant human tumour necrolysis factor-alpha
US7642340B2 (en) * 2003-03-31 2010-01-05 Xencor, Inc. PEGylated TNF-α variant proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582183D1 (de) * 1984-03-06 1991-04-25 Dainippon Pharmaceutical Co Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
WO1986002381A1 (en) * 1984-10-15 1986-04-24 Cetus Corporation Human tumor necrosis factor
EP0205038A1 (en) * 1985-05-29 1986-12-17 Suntory Limited Polypeptide, process for preparing it, microorganism and pharmaceutical use

Also Published As

Publication number Publication date
NO864321D0 (no) 1986-10-29
FI864412A (fi) 1987-05-01
EP0220966A2 (en) 1987-05-06
EP0220966A3 (en) 1989-08-23
IL80448A (en) 1991-01-31
NZ218103A (en) 1988-10-28
CA1286843C (en) 1991-07-23
NO864321L (no) 1987-05-04
DK520086A (da) 1987-05-01
DK520086D0 (da) 1986-10-30
IL80448A0 (en) 1987-01-30
AU6449586A (en) 1987-05-07
FI864412A0 (fi) 1986-10-29

Similar Documents

Publication Publication Date Title
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
AU5301486A (en) Purification, production and use of tumor necrosis factors
SE8204382D0 (sv) Process for producing target cell lysis factor and uses therewith
ATE107535T1 (de) Gaschromatographische methode zur trennung von wasserstoffisotopen.
EP0154620A3 (en) Structure with membranes having pores extending throughout, process for producing this structure and its uses
ES8600690A1 (es) Procedimiento de purificar factores antihemofilicos y similares
CO5241324A1 (es) Procedimiento para la purificacion de eritropoyetina humana recombinante a partir de sobrenadantes de cultivo de celulas . .
ATE359301T1 (de) Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
MX166995B (es) Purificacion del factor de necrosis tumoral mediane membranas de politetrafluroetileno microporosas
GB1178892A (en) Improved process of Purifying Isomerized Liquors
ES2070855T3 (es) Metodo para purificar una proteina.
KR840003422A (ko) 균질한 인체 면역 인터페론의 제조방법
DK1103618T3 (da) Fremgangsmåde til oprensning af 1,3-propandiol fra fermenteringsmedie
AU583388B2 (en) High performance liquid chromatography mobile phase
Hammarström Configuration of 2‐hydroxy acids from brain cerebrosides determined by gas chromatography
Ross et al. Chemical and electrochemical oxidation of 2, 5-dimethylfuran to 2, 5-dimethyl-2, 5-dimethoxydihydrofuran
ES443458A1 (es) Un procedimiento de recuperacion del antibiotico tienamicinade los caldos de fermentacion.
ATE168097T1 (de) Verfahren zur reinigung von mittleren olefinen
ES557766A0 (es) Procedimiento de fabricacion de anodos de carbon en especial para la produccion de aluminio por electrolisis.
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
IT8567141A1 (it) Procedimento per le coltura di cellule, mediante dispersione di gas.
Sowden et al. Concerning the mechanism of formation of saccharinic acids
JPS5777958A (en) Affinitive adsorbent for affnity chromatography
SU609547A1 (ru) Раствор дл очистки газов от окислых компонентов
RU1839190C (ru) Способ очистки микробной эстеразы